Chemotherapy Preparation and Dispensing

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/117

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 2:42 AM on 9/7/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

118 Terms

1
New cards

hazardous drug

Drug that meets at least 1 of the following:

• Carcinogenic

• Teratogenic

• Fertility impairment

• Organ toxicity at low doses (

2
New cards

carcinogenic

cancer causing

3
New cards

teratogenic

causes congenital disabilities

4
New cards

genotoxicity

damages DNA, which can cause cancer

5
New cards

yes

Can exposure to hazardous drugs cause acute and long term AEs?

6
New cards

contaminated surfaces

What is the most common route of exposure with hazardous drugs?

7
New cards

skin, ocular, flu-like symptoms, HA

What are the acute reactions with exposure to hazardous drugs?

8
New cards

fetal abnormalities, loss of fertility, secondary cancers

What are the chronic reactions with exposure to hazardous drugs?

9
New cards

- Inhalation

- Accidental injection

- Ingestion of contaminated food or mouth contact with contaminated hands

- Dermal contact with contaminated surface

What are the routes of exposure with hazardous drugs?

10
New cards

non-chemo hazardous drugs

• Warfarin

• Fluconazole

• Isotretinoin

• Dronedarone

• Finasteride

• Paroxetine

• Phenytoin

• Colchicine

• Spironolactone

• Estrogens

• Progesterone

• Temazepam

• Cyclosporine

• Liraglutide

11
New cards

USP

provides regulatory standards for sterile compounding

12
New cards

USP 797

outlines sterile product preparation

13
New cards

USP 800

describes handling strategies for HD

14
New cards

ASHP

provides information on implementing recommendations and requirements for handling and compounding hazardous drugs

15
New cards

low risk hazardous drugs

-Limited risk of causing harm

-Counting and packaging tablets

-Do not require following all USP 800 requirements

-Safety Measures:

• Dedicated tray for counting

• Use of gloves

-Examples: finasteride, misoprostol

16
New cards

PIC

Who makes the rules on how you treat low risk hazardous drugs?

17
New cards

high risk hazardous drugs

• High risk of causing harm

• IV compounding; splitting tablets

• Must follow USP 800 requirements

• Example: IV chemotherapy

18
New cards

USP

Who makes the rules when handling high risk hazardous drugs?

19
New cards

-neg pressure room

-room externally vented

-a vertical flow biological safety cabinet

-appropriate air changes per hr

What is required per USP 800 in a compounding area?

20
New cards

at least 30 per hr in a room where the hood is located

What is the appropriate air change amount per hour in a compounding area per USP 800?

21
New cards

personal protective equipment per USP 800

- Double gloves or chemo rated gloves

- Impermeable gowns

- Double shoe covers

- Respiratory protection for spills/cleaning

• Dress from "dirtiest to cleanest"

- Exact order may differ between settings (shoes, hair, mask, gown, gloves)

22
New cards

Closed System Drug Transfer Device (CSTD)

-"a drug transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of the hazardous drug or vapor concentrations outside the system."

- Recommended to use throughout HD-handling chain from compounding to patient administration

23
New cards

negative

Hazardous drugs must be stored in a __________ pressure room.

24
New cards

segregate

You should __________ HD stock from other inventory.

25
New cards

must

Staff ______ wear gloves when handling HD inventory.

26
New cards

distinctive labels

Drug packages and storage areas must bear __________ for special handling precautions

27
New cards

PRONTO

Use of a standardized checklist can help reduce risk of error

28
New cards

patient

What does the P in PRONTO stand for?

29
New cards

regimen

What does the R in PRONTO stand for?

30
New cards

Organ system

What does the O in PRONTO stand for?

31
New cards

Numbers

What does the N in PRONTO stand for?

32
New cards

Toxicity

What does the T in PRONTO stand for?

33
New cards

Order verification

What does the O in PRONTO stand for?

34
New cards

Patient part in PRONTO

Review chart to gain an overview of the patient.

- What type of malignancy does the patient have?

- What is the goal of treatment? (curative vs palliative)

- What is the patient's performance status (ECOG score)?

- What type of line access does the patient have? (Central versus peripheral)

- What is the current treatment?

- What are current lab values?

35
New cards

ECOG 0

Fully active, able to carry on all pre-disease performance without restriction

36
New cards

ECOG 1

Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; e.g. light house work, office work

37
New cards

ECOG 2

Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours

38
New cards

ECOG 3

Capable of only limited self care, confined to bed or chair more than 50% of waking hours

39
New cards

ECOG 4

Completely disabled. Cannot carry on any self care. Totally confined to bed or chair

40
New cards

ECOG 5

dead

41
New cards

typically 0-2

What ECOG scores do we typically consider tx for?

42
New cards

typically 3-5

What ECOG scores do we typically consider comfort care for?

43
New cards

Regimen/dose part in PRONTO

Does the regimen match a published regimen and make sense for the patient?

- Do you have a reference that supports the regimen?

- Is the patient due for chemo based on cycle and day?

- Is the dosing of chemotherapy appropriate?

• Dose, route, dilution fluid, rate

- Is the sequencing of chemotherapy appropriate?

44
New cards

safety

What is the primary responsibility at the R-regimen/dose step in PRONTO?

45
New cards

drug information resources (Lexi, Micromedex)

these references are the least helpful with dosing regimens

46
New cards

cycle

how frequent the regimen is repeated

47
New cards

day

the day of each cycle the medication is given

48
New cards

1)vesicant -> irritant -> nonvesicant

2) efficacy/safety

3) stability

What is the sequencing of chemo?

49
New cards

less

The _____ stable agents of chemo should go first.

50
New cards

Organ function/labs part in PRONTO

Do the patient's organ function and labs warrant full dose treatment?

- CBC

- Electrolytes

- Renal Function (CrCl)

- Liver Function

- Urinalysis

- Echocardiogram/EKG

51
New cards

organ function/labs section to determine appropriate dosage adjustments and monitoring

When should you use drug info resources in PRONTO?

52
New cards

Numbers part in PRONTO

Dose Calculations

- CrCl

- BSA

- AUC

Admixture and Administration Numbers

- Concentrations

- Rate of Infusion

- Fluid type

53
New cards

BSA

estimate of cardiac output and distribution to the liver and kidneys and is commonly used for dosing in chemo

54
New cards

Carboplatin Dose (mg)= target AUC x (GFR + 25)

What is the Calvert Equation used for AUC dosing of Carboplatin?

55
New cards

Toxicities part in PRONTO

Does patient have appropriate medications to

prevent toxicities?

- Nausea/Vomiting?

- Infusion related reactions?

- Neutropenia?

- Tumor lysis syndrome?

Any risk of drug-drug interactions with other medications?

56
New cards

Order verification part in PRONTO

1. Independent Double Check of "PRONT" step

2. Compare chemotherapy order, label and product

57
New cards

Extravasation

The inadvertent instillation or leakage of a cytotoxic drug into the perivascular space during infusion

58
New cards

Irritant

• May induce a local inflammatory response

• Short-term injury; does not lead to tissue necrosis/injury

• Vein may be tender or have burning/erythema

• Blood return remains intact

59
New cards

Vesicant

• Severe necrosis; erythema and blistering of skin around extravasation

• May take up to 6-12 hrs for symptoms to appear

• Blood return is absent

• Anthracyclines, taxanes, vinca alkaloids

60
New cards

-use central catheter

-educate pt on s/s to report

-check for blood flow throughout admin

-bolus doses of irritant/vesicant chemo should be given over 5-10 mins through a free-flowing IV line

What are the ways to prevent extravasation?

61
New cards

pain, redness, swelling at injection site

What should the patient look out for to alert us that extravasation may be taking place?

62
New cards

extravasation tx

1. Stop infusion

2. Aspirate any drug via the intravenous cannula

3. Do NOT flush the line

4. Remove the catheter/needle

5. Elevate and immobilize the affected limb

6. Apply cold or warm packs as recommended (Warm: Vinca alkaloids; Cold- most everything else)

7. Administer antidote, if available

8. Photograph site and/or mark around area with permanent marker

9. Monitor site closely for 24 hrs and up to 2 weeks for redness, swelling, pain, ulceration, and/or necrosis

63
New cards

Dexrazoxane

-admin: IV infusion

-MOA: Prevent free-radical formation and reduce oxidative stress

-useful against Anthracyclines

64
New cards

Dimethyl sulfoxide (DMSO)

-admin: topical

-MOA: Neutralizes free radicals, promotes absorption of vesicant

-usedful against Anthracyclines, Cisplatin

65
New cards

Hyaluronidase

-admin: SC into infiltration site

-MOA: accelerates local connective tissue breakdown and absorption

-useful against Vinca or taxanes

66
New cards

Sodium thiosulfate

-admin: SC injection into infiltration site

-MOA: binds and neutralizes vesicant

-useful against Cisplatin

67
New cards

no

Are all tumors with (-omas) at the end malignant?

68
New cards

BSA

is believed to be a more accurate measure that eliminates"adipose" effects. Criticized for not taking into account inter-patient variation in pharmacokinetics and PGx.

69
New cards

-hormone therapy

-surgery

-bone marrow transplantation

-immunotherapy

-radiation therapy

-targeted therapy

-chemotherapy

What are the conventional tx options for cancer?

70
New cards

-surgery

-radiotherapy

-cytotoxic chemotherapy

-molecularly targeted therapy

-immunotherapy

What are the pillars of cancer care?

71
New cards

gene therapy

What will be the new and upcoming pillar of cancer care?

72
New cards

Neoadjuvant

Chemotherapy delivered BEFORE the main treatment, to help reduce the sizeof a tumor or kill cancer cells that have spread. In many cancers, its used to down stage select patients with malignant tumors, thereby rendering the primary tumors and metastases resectable in some cases

73
New cards

Adjuvant

Chemotherapy delivered AFTER primary treatment which attempts to eliminate micrometastasis; given to prevent a possible cancer recurrence

74
New cards

First line chemotherapy

Chemotherapy determined to have the best probability of treating a given cancer. This may also be called standard therapy.

75
New cards

Second line chemotherapy

Chemotherapy that is given if a disease has not responded or reoccurred after first line chemotherapy. In some cases, this may also be referred to as salvage therapy.

76
New cards

Palliative

Chemotherapy aimed at improving or managing symptoms

77
New cards

Curative

Elimination of all known tumor mass (Complete and Durable Response)

78
New cards

narrow

The therapeutic window for most cancer drugs is _________

79
New cards

wider

The ________ the therapeutic window the better.

80
New cards

therapeutic index

toxic dose/effective dose

81
New cards

safer

A therapeutic index of 3 or greater is a _______ drug.

82
New cards

adverse effects (off-target) of chemo

-alopecia

-mucositis

-pulmonary fibrosis

-N/V

-cardiotox

-Diarrhea

-Local reaction

-Cystitis

-Renal failure

-Sterility

-Myelosuppression

-Myalgia

-Neuropathy

-Phlebitis

83
New cards

• 5HT3 receptor antagonist (-setron class)

• Dexamethasone

• NK1 receptor antagonist (-pitant class)

Drug classes that treat CINV (nausea and vomiting)

84
New cards

no FDA approved therapies...yet (duloxetine)

Drug classes that treat CIPN (peripheral neuropathy)

85
New cards

bisphosphonates

Drug classes that treat bone loss (CIBL)

86
New cards

neutrophil enhancers

Drug classes that treat neutropenia (CIN) and febrile neutropenia (CIFN

87
New cards

platelet enhancers

Drug classes that treat thrombocytopenia (CIT)

88
New cards

erythropoietin stimulating agents (ESA)

Drug classes that treat anemia (CIA)

89
New cards

1) a therapy that targets

2) a population of cancer cells

3) a particular host environment

What is the 3 component system of cancer therapy?

90
New cards

intrinsic resistance

exists before drug tx

91
New cards

acquired resistance

is induced after therapy

92
New cards

50%

What % of cancer pts have drug resistance?

93
New cards

staging

describes the extent or spread of disease at the time of diagnosis

94
New cards

cancer extent and severity

What is staging in cancer used to gauge?

95
New cards

-summary

-TMN

What are the 2 staging systems generally used with cancer?

96
New cards

The Summary Staging System

more general of a system for staging

97
New cards

-in situ

-localized

-regional

-distant (metastatic)

What are the 4 main types of the summary staging system?

98
New cards

in situ

is early cancer that is present only in the layer of cells in which it began

99
New cards

localized

is cancer that is limited to the organ in which it began, without evidence of spread

100
New cards

regional

is cancer that has spread beyond the original (primary) site to nearby lymph nodes or organs and tissues